- Home
- CRVS vs SHBI Comparison
CRVS vs SHBI Comparison
Compare CRVS & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- SHBI
- Stock Information
- Founded
- CRVS 2014
- SHBI 1876
- Country
- CRVS United States
- SHBI United States
- Employees
- CRVS N/A
- SHBI N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- SHBI Major Banks
- Sector
- CRVS Health Care
- SHBI Finance
- Exchange
- CRVS Nasdaq
- SHBI Nasdaq
- Market Cap
- CRVS 459.0M
- SHBI 548.4M
- IPO Year
- CRVS 2016
- SHBI N/A
- Fundamental
- Price
- CRVS $8.04
- SHBI $15.61
- Analyst Decision
- CRVS Strong Buy
- SHBI Buy
- Analyst Count
- CRVS 4
- SHBI 1
- Target Price
- CRVS $13.75
- SHBI $20.00
- AVG Volume (30 Days)
- CRVS 1.1M
- SHBI 137.4K
- Earning Date
- CRVS 11-04-2025
- SHBI 10-23-2025
- Dividend Yield
- CRVS N/A
- SHBI 3.07%
- EPS Growth
- CRVS N/A
- SHBI 38.19
- EPS
- CRVS N/A
- SHBI 1.71
- Revenue
- CRVS N/A
- SHBI $212,493,000.00
- Revenue This Year
- CRVS N/A
- SHBI N/A
- Revenue Next Year
- CRVS N/A
- SHBI $6.89
- P/E Ratio
- CRVS N/A
- SHBI $9.15
- Revenue Growth
- CRVS N/A
- SHBI 10.07
- 52 Week Low
- CRVS $2.54
- SHBI $11.47
- 52 Week High
- CRVS $10.00
- SHBI $17.67
- Technical
- Relative Strength Index (RSI)
- CRVS 64.17
- SHBI 43.73
- Support Level
- CRVS $7.46
- SHBI $15.45
- Resistance Level
- CRVS $7.96
- SHBI $16.10
- Average True Range (ATR)
- CRVS 0.56
- SHBI 0.53
- MACD
- CRVS 0.01
- SHBI 0.00
- Stochastic Oscillator
- CRVS 75.46
- SHBI 41.90
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.